Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

New antiplatelet drugs from Takeda

Dec. 23, 1996

New antithrombotic agents described by Pfizer

Dec. 23, 1996

Corvas and Schering-Plough expand antithrombotic collaboration

Dec. 18, 1996

New antiplatelet agents described by Thomae

Dec. 17, 1996

FDA panel recommends approval of BeneFix

Dec. 13, 1996

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Dec. 13, 1996

Novel mechanism of action reported for Xenova PAI inhibitor

Dec. 13, 1996

Warfarin underused for stroke prevention

Dec. 11, 1996

Antithrombin III advances to phase II

Dec. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...